Free shipping on all orders over $ 500

Cobicistat

Cat. No. M2537

All AbMole products are for research use only, cannot be used for human consumption.

Cobicistat  Structure
Synonym:

GS-9350

Size Price Availability Quantity
10mg USD 165 In stock
50mg USD 490 In stock
100mg USD 700 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Cobicistat (GS-9350) is a potent and selective inhibitor of CYP3A with IC50 of 30-285 nM.

Chemical Information
Molecular Weight 776.02
Formula C40H53N7O5S2
CAS Number 1004316-88-4
Solubility (25°C) DMSO ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Lianhong Xu, et al. ACS Med Chem Lett. Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer

Related Cytochrome P450 (e.g. CYP17) Products
Abiraterone

Abiraterone acetate (CB-7598) is a potent, selective, and orally available inhibitor of CYP17 with an IC50 of 4 nM.

Avasimibe

Avasimibe (CI-1011) is a novel orally bioavailable ACAT inhibitor with IC50 values of 2.9, 13.9, 26.5 µM for CYP2C9, CYP1A2 and CYP2C19, respectively.

Imidaclopride

Imidaclopride is a systemic insecticide which acts as an insect neurotoxin and belongs to a class of chemicals called the neonicotinoids.

Ketoconazole

Ketoconazole (R-41400) is an imidazole anti-fungal agent, a CYP3A4 and CYP24A1 inhibitor.

Chrysin

Chrysin is a naturally occurring flavone chemically extracted from the passion flowers Passiflora caerulea.

  Catalog
Abmole Inhibitor Catalog




Keywords: Cobicistat , GS-9350 supplier, Cytochrome P450 (e.g. CYP17), inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.